SEC Comment Letter 0000000000-24-009096 to Longeveron Inc. (LGVN)
Longeveron Inc.
Date: Aug. 8, 2024 · CIK: 0001721484 · Accession: 0000000000-24-009096
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281299
Letter
August 8, 2024 Wa’el Hashad Chief Executive Officer Longeveron Inc. 1951 NW 7th Avenue, Suite 520 Miami, Florida 33136 Re:Longeveron Inc. Registration Statement on Form S-1 Filed August 6, 2024 File No. 333-281299 Dear Wa’el Hashad: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jennifer Minter, Esq.
Show Raw Text
August 8, 2024
Wa’el Hashad
Chief Executive Officer
Longeveron Inc.
1951 NW 7th Avenue, Suite 520
Miami, Florida 33136
Re:Longeveron Inc.
Registration Statement on Form S-1
Filed August 6, 2024
File No. 333-281299
Dear Wa’el Hashad:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jennifer Minter, Esq.